Patents by Inventor Liang Jiang

Liang Jiang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150083281
    Abstract: A high temperature component having an actuator body including an actuatable portion comprising a shape memory alloy containing one more of Ni, Al, Nb, Ti and Ta and a platinum-group metal. The shape memory alloy has an altered geometry at a predetermined temperature. The actuator is also capable of operation in and is resistant to high temperature oxidizing atmospheres. A method for forming an actuator and a method for high temperature control are also disclosed.
    Type: Application
    Filed: February 27, 2008
    Publication date: March 26, 2015
    Applicant: General Electric Company
    Inventors: Don Mark Lipkin, Liang Jiang, Ronald Scott Bunker
  • Patent number: 8966132
    Abstract: According to embodiments of the invention, methods, computer readable storage medium, and a computer system for determining a mapping mode for a DMA data transfer are disclosed. The method may include receiving a request for a DMA data transfer within a computer system. The method may also include determining a mapping mode for the DMA data transfer based on available system profile data in response to receiving the request. The method may also include mapping the memory using the determined mapping mode.
    Type: Grant
    Filed: November 16, 2012
    Date of Patent: February 24, 2015
    Assignee: International Business Machines Corporation
    Inventors: Brian W. Hart, Liang Jiang, Anil Kalavakolanu
  • Patent number: 8965462
    Abstract: Personal digital assistant devices are provided that query power subsystems to determine a level of battery power currently available for operating processes, and further determine a number of screen display changes that may be effected on a persistent display device at that determined level. If the determined number of screen display changes that may be effected at the determined level of available battery power fails to meet a specified minimum threshold number of images, the processing unit powers down subsystems of the personal digital assistant device and causes a highest listed image of a prioritized list of screen image instances to be displayed on the persistent display device, which persistently displays the image after a loss of power.
    Type: Grant
    Filed: July 25, 2012
    Date of Patent: February 24, 2015
    Assignee: International Business Machines Corporation
    Inventors: Brian W. Hart, Liang Jiang, Anil Kalavakolanu, Minh M. Pham, Stephen A. Schlachter
  • Patent number: 8966133
    Abstract: According to embodiments of the invention, methods, computer readable storage medium, and a computer system for determining a mapping mode for a DMA data transfer are disclosed. The method may include receiving a request for a DMA data transfer within a computer system. The method may also include determining a mapping mode for the DMA data transfer based on available system profile data in response to receiving the request. The method may also include mapping the memory using the determined mapping mode.
    Type: Grant
    Filed: January 13, 2014
    Date of Patent: February 24, 2015
    Assignee: International Business Machines Corporation
    Inventors: Brian W. Hart, Liang Jiang, Anil Kalavakolanu
  • Publication number: 20150052279
    Abstract: The present disclosure includes a method for migration of a first virtual function of a first device located on a PCI bus and accessible by a device driver using a virtual address. A second virtual function is created on a second device. A base address is determined for the second virtual function as a function of a logical location of the second device within the PCI structure. An offset is determined for the second virtual function as a function of the base address and the virtual address. The device driver is notified that the first virtual function is on hold. The offset is stored in a translation table. The device driver is notified that the hold has been lifted. Accesses to the virtual address and by the device driver to memory of the second virtual function are routed based upon the offset in the translation table.
    Type: Application
    Filed: August 19, 2013
    Publication date: February 19, 2015
    Applicant: International Business Machines Corporation
    Inventors: Brian W. Hart, Liang Jiang, Anil Kalavakolanu, Shannon D. Moore, Robert E. Wallis, Evelyn T. Yeung
  • Publication number: 20150052281
    Abstract: The present disclosure includes a method for migration of a first virtual function of a first device located on a PCI bus and accessible by a device driver using a virtual address. A second virtual function is created on a second device. A base address is determined for the second virtual function as a function of a logical location of the second device within the PCI structure. An offset is determined for the second virtual function as a function of the base address and the virtual address. The device driver is notified that the first virtual function is on hold. The offset is stored in a translation table. The device driver is notified that the hold has been lifted. Accesses to the virtual address and by the device driver to memory of the second virtual function are routed based upon the offset in the translation table.
    Type: Application
    Filed: December 10, 2013
    Publication date: February 19, 2015
    Applicant: International Business Machines Corporation
    Inventors: Brian W. Hart, Liang Jiang, Anil Kalavakolanu, Shannon D. Moore, Robert E. Wallis, Evelyn T. Yeung
  • Publication number: 20150009746
    Abstract: A system comprising a solid state lattice containing an electronic spin coupled to a nuclear spin; an optical excitation configuration which is arranged to generate first optical radiation to excite the electronic spin to emit output optical radiation without decoupling the electronic and nuclear spins; wherein the optical excitation configuration is further arranged to generate second optical radiation of higher power than the first optical radiation to decouple the electronic spin from the nuclear spin thereby increasing coherence time of the nuclear spin; a first pulse source configured to generate radio frequency (RF) excitation pulse sequences to manipulate the nuclear spin and to dynamically decouple the nuclear spin from one or more spin impurities in the solid state lattice so as to further increase the coherence time of the nuclear spin; a second pulse source configured to generate microwave excitation pulse sequences to manipulate the electronic spin causing a change in intensity of the output optic
    Type: Application
    Filed: December 23, 2012
    Publication date: January 8, 2015
    Applicant: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
    Inventors: Georg Kucsko, Peter Maurer, Liang Jiang, Norman Yao, Mikhail Lukin
  • Patent number: 8926963
    Abstract: The specification discloses compositions and methods for treating a soft tissue defect of an individual.
    Type: Grant
    Filed: February 16, 2012
    Date of Patent: January 6, 2015
    Assignee: Allergan, Inc.
    Inventors: Dennis E. Van Epps, Guang-Liang Jiang, Adam L. Collette, Rebecca L. Horan, Jingsong Chen, Gregory H. Altman, Wha Bin Im
  • Publication number: 20140358793
    Abstract: A quantum ticket is defined by a unique serial number; and a set of qubits, each qubit encoding quantum information. The serial number and the set of qubits are distributed only among one or more trusted verifiers who require a tolerance fidelity Ftol in order to authenticate the token, where Ftol represents a minimum percentage of correct outcomes during authentication of the serial number and the set of qubits. The experimental fidelity Fexp for the quantum token is greater than the Ft0i set by the verifiers, so that an honest user of the quantum ticket who achieves Fexp is exponentially likely to be successfully authenticated when seeking authentication by any of the trusted verifiers. The forging fidelity Fforg for the quantum token is less than Ft0i, so that a dishonest user who achieves Fforg and attempts forgery of the quantum ticket is exponentially likely to fail to obtain authentication for his forged ticket.
    Type: Application
    Filed: December 23, 2012
    Publication date: December 4, 2014
    Applicant: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
    Inventors: Fernando Pastawski, J. Ignacio Cirac, Liang Jiang, Norman Yao, Mikhail Lukin
  • Patent number: 8900571
    Abstract: The invention relates to compositions comprising a silk fibroin material, adipose tissue and a compound of the structure where X1 and X5 are independently CH or N; X7 is NH, O or S; X8 and X9 are independently CH or N; R13 is an optionally substituted aryl or optionally substituted heteroaryl and R14 is C1-6 alkyl, optionally substituted aryl or optionally substituted heteroaryl. The composition is administered to a site of a soft tissue condition including those of breast tissue. The silk fibroin material can be in the form of a silk hydrogel, a silk film, a silk scaffold, a silk sheet, a silk porous material or a silk fiber. The silk fibroin material can be substantially sericin free.
    Type: Grant
    Filed: February 16, 2012
    Date of Patent: December 2, 2014
    Assignee: Allergan, Inc.
    Inventors: Dennis E. Van Epps, Guang-Liang Jiang, Adam L. Collette, Rebecca L. Horan, Jingsong Chen, Gregory H. Altman, Wha Bin Im
  • Patent number: 8894992
    Abstract: The invention relates to compositions comprising adipose tissue, a silk fibroin material and a compound of the structure The composition is administered to a site of a soft tissue condition including those of breast tissue. The silk fibroin material can be in the form of a silk hydrogel, a silk film, a silk scaffold, a silk sheet, a silk porous material, a silk fiber or a combination of those materials. The silk material may be substantially sericin free.
    Type: Grant
    Filed: February 16, 2012
    Date of Patent: November 25, 2014
    Assignee: Allergan, Inc.
    Inventors: Dennis E. Van Epps, Guang-Liang Jiang, Adam L. Collette, Rebecca L. Horan, Jingsong Chen, Gregory H. Altman, Wha Bin Im
  • Patent number: 8889123
    Abstract: The invention relates to compositions comprising a hydrogel material that comprises a glycosaminoglycan polymer, adipose tissue and a compound of the structure where X1 and X5 are independently CH or N; X7 is NH, O or S; X8 and X9 are independently CH or N; R13 is an optionally substituted aryl or optionally substituted heteroaryl and R14 is C1-6 alkyl, optionally substituted aryl or optionally substituted heteroaryl. The composition is administered to a site of a soft tissue condition including those of breast tissue. The hydrogel material can be porous or of solid particles. The glycosaminoglycan polymer can be a hyaluronan polymer.
    Type: Grant
    Filed: February 16, 2012
    Date of Patent: November 18, 2014
    Assignee: Allergan, Inc.
    Inventors: Dennis E. Van Epps, Guang-Liang Jiang, Wha Bin Im
  • Patent number: 8883139
    Abstract: The invention relates to compositions comprising a hydrogel material that comprises a glycosaminoglycan polymer, adipose tissue and a compound of the structure The composition is administered to a site of a soft tissue condition including those of breast tissue. The hydrogel material can be porous or of solid particles. The glycosaminoglycan polymer can be a hyaluronan polymer.
    Type: Grant
    Filed: February 16, 2012
    Date of Patent: November 11, 2014
    Assignee: Allergan Inc.
    Inventors: Dennis E. Van Epps, Guang-Liang Jiang, Wha Bin Im
  • Patent number: 8880858
    Abstract: Illustrative embodiments include a method, system, and computer program product for estimating boot-time memory requirement of a data processing system. A data processing system identifies, using system configuration information associated with the data processing system, a set of components needed for booting up the data processing system. The data processing system determines a dependency of a component identified in the set of components, the component including a memory estimator program. The data processing system determines an ancestry of the component identified in the set of components. The data processing system receives, using the memory estimator program of the component, a boot-time memory requirement of the component. The data processing system calculates a total boot-time memory requirement. The data processing system determines whether an amount of real memory of the data processing system satisfies the total boot-time memory requirement.
    Type: Grant
    Filed: May 6, 2011
    Date of Patent: November 4, 2014
    Assignee: International Business Machines Corporation
    Inventors: Vishal Chittranjan Aslot, Adekunle Bello, Liang Jiang
  • Publication number: 20140179752
    Abstract: The specification discloses compositions and methods for treating a soft tissue defect of an individual.
    Type: Application
    Filed: February 25, 2014
    Publication date: June 26, 2014
    Applicant: Allergan, Inc.
    Inventors: Dennis E. Van Epps, Guan-Liang Jiang, Wha Bin Im
  • Publication number: 20140170234
    Abstract: The present specification discloses compositions and methods of transplanting tissue, for example, in breast augmentation procedures. The compositions include adipose tissue and compounds that reduce tissue volume loss and increase survival rate of the adipose tissue when the composition is introduced into breast tissue.
    Type: Application
    Filed: February 25, 2014
    Publication date: June 19, 2014
    Applicant: Allergan, Inc.
    Inventors: Dennis E. Van Epps, Guan-Liang Jiang, Wha Bin Im
  • Patent number: 8741281
    Abstract: The specification discloses compositions and methods for treating a soft tissue defect of an individual.
    Type: Grant
    Filed: February 16, 2012
    Date of Patent: June 3, 2014
    Assignee: Allergan, Inc.
    Inventors: Dennis E. Van Epps, Guang-Liang Jiang, Adam L. Collette, Rebecca L. Horan, Jingsong Chen, Gregory H. Altman, Wha Bin Im
  • Publication number: 20140143456
    Abstract: According to embodiments of the invention, methods, computer readable storage medium, and a computer system for determining a mapping mode for a DMA data transfer are disclosed. The method may include receiving a request for a DMA data transfer within a computer system. The method may also include determining a mapping mode for the DMA data transfer based on available system profile data in response to receiving the request. The method may also include mapping the memory using the determined mapping mode.
    Type: Application
    Filed: November 16, 2012
    Publication date: May 22, 2014
    Applicant: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Brian W. Hart, Liang Jiang, Anil Kalavakolanu
  • Publication number: 20140143457
    Abstract: According to embodiments of the invention, methods, computer readable storage medium, and a computer system for determining a mapping mode for a DMA data transfer are disclosed. The method may include receiving a request for a DMA data transfer within a computer system. The method may also include determining a mapping mode for the DMA data transfer based on available system profile data in response to receiving the request. The method may also include mapping the memory using the determined mapping mode.
    Type: Application
    Filed: January 13, 2014
    Publication date: May 22, 2014
    Applicant: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Brian W. Hart, Liang Jiang, Anil Kalavakolanu
  • Patent number: 8697059
    Abstract: The present specification discloses compositions and methods for use in breast augmentation procedures. The compositions include adipose tissue and compounds that upregulate both FGF-2 and VEGF, promote new blood vessel formation thereby reducing tissue volume loss and increasing survival rate of the adipose tissue when the composition is introduced into breast tissue.
    Type: Grant
    Filed: May 3, 2013
    Date of Patent: April 15, 2014
    Assignee: Allergan, Inc.
    Inventors: Dennis Van Epps, Guang-Liang Jiang, Wha Bin Im